Myricetin-induced suicidal erythrocyte death

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Myricetin, a flavonol from plants, exhibits anticancer properties by inducing apoptosis.
• Eryptosis, or programmed cell death in erythrocytes, occurs without mitochondria or nuclei.
• Eryptosis involves cell shrinkage, phosphatidylserine exposure, and membrane blebbing, regulated by calcium, ROS, and ceramide.

Purpose of the Study:

• To investigate the effects of myricetin on eryptosis in human erythrocytes.
• To determine the role of calcium, reactive oxygen species, and ceramide in myricetin-induced eryptosis.

Main Methods:

• Human erythrocytes were treated with varying myricetin concentrations (2-8 µM).
• Flow cytometry assessed phosphatidylserine exposure, cell volume, and intracellular calcium.
• Reactive oxygen species (ROS) levels were measured using DCFDA assay; ceramide accumulation was quantified.

Main Results:

• Myricetin (8 µM) significantly increased Annexin-V positive cells, indicating phosphatidylserine exposure.
• Myricetin elevated intracellular calcium (Fluo-3) and ROS (DCF fluorescence).
• Ceramide accumulation was significantly increased in myricetin-treated erythrocytes; calcium removal partially reduced annexin-V binding.

Conclusions:

• Myricetin effectively triggers eryptosis in human erythrocytes.
• Calcium influx, oxidative stress, and increased ceramide are key mediators of myricetin-induced eryptosis.
• Myricetin's effects on eryptosis suggest potential implications for red blood cell disorders.